http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2387038-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-14
filingDate 1978-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1978-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2387038-A1
titleOfInvention PROCESS FOR ACTIVATING THE ABSORPTION OF ANTI-TUMOR AGENT IN THE LOCATION OF A GASTROINTESTINAL TUMOR AND ANTI-TUMOR COMPOSITIONS THAT CAN BE ADMINISTERED ORALLY CONTAINING THIS AGENT
abstract A method of promoting absorption of an anti-tumor agent in the site of a gastrointestinal tumor and anti-tumor compositions which can be administered orally containing this agent. The present invention relates to a method for selectively activating the absorption of 5-fluoro-uracil, bleomycins or bleomycin derivatives in the location of a gastrointestinal tumor by oral administration of this substance mixed with a salt of. alkali metal of polyacrylic acid, and it also relates to an anti-tumor composition which can be administered orally used for this method. This composition prevents the accumulation of the active drug in the bone marrow.
priorityDate 1977-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3975516-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504969

Total number of triples: 21.